Neurobiochemical Markers of Brain Damage in Cerebrospinal Fluid of Acute Ischemic Stroke Patients
- 1 March 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 56 (3) , 451-458
Abstract
Background: Ischemic injury to the central nervous system causes cellular activation and disintegration, leading to release of cell-type–specific proteins into the cerebrospinal fluid (CSF). We investigated CSF concentrations of myelin basic protein (MBP), glial fibrillary astrocytic protein (GFAP), the calcium-binding protein S100B, and neuron-specific enolase (NSE) in acute ischemic stroke patients and their relation to initial stroke severity, stroke location, and long-term stroke outcome. Methods: CSF concentrations of MBP, GFAP, S100B, and NSE were assessed in 89 stroke patients on admission (mean 8.7 h after stroke onset) and in 35 controls. We evaluated the relation between CSF concentrations and (a) stroke severity (NIH Stroke Scale [NIHSS] score on admission, infarct volume), (b) stroke location, and (c) stroke outcome (modified Rankin Scale [mRS] score at month 3). Results: MBP concentration was significantly higher in subcortical than in cortical infarcts (median MBP, 1.18 vs 0.66 μg/L, P < 0.001). GFAP and S100B concentrations correlated with the NIHSS score on admission (GFAP, R = 0.35, P = 0.001; S100B, R = 0.29, P = 0.006), infarct volume (GFAP, R = 0.34, P = 0.001; S100B, R = 0.28, P = 0.008), and mRS score at month 3 (R = 0.42, P < 0.001 and R = 0.28, P = 0.007). Concentrations of NSE did not correlate with stroke characteristics. Conclusions: MBP, GFAP, S100B, and NSE display relevant differences in cellular and subcellular origins, which are reflected in their relation to stroke characteristics. MBP is a marker for infarct location. GFAP and S100B correlate with stroke severity and outcome.Keywords
Funding Information
- Medical Research Foundation
This publication has 30 references indexed in Scilit:
- Invited Article: Searching for oracles?Neurology, 2009
- The complexity of neurobiological processes in acute ischemic strokeClinical Neurology and Neurosurgery, 2009
- Glial and Axonal Body Fluid Biomarkers Are Related to Infarct Volume, Severity, and OutcomeJournal of Stroke and Cerebrovascular Diseases, 2008
- A Critical Analysis of the Role of the Neurotrophic Protein S100B in Acute Brain InjuryJournal of Neurotrauma, 2006
- The increase of neuron-specific enolase in cerebrospinal fluid and plasma as a marker of neuronal damage in patients with acute brain infarctionJournal of Clinical Neuroscience, 2005
- Cerebrospinal fluid (CSF) and serum S100B: release and wash-out patternBrain Research Bulletin, 2003
- Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sourcesThe Annals of Thoracic Surgery, 2001
- Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction.Stroke, 1991
- Brain and plasma proteins in spinal fluid as markers for brain damage and severity of stroke.Stroke, 1984
- Myelin basic protein demonstrated immunocytochemically in oligodendroglia prior to myelin sheath formation.Proceedings of the National Academy of Sciences, 1978